ArticleIndian journal of ophthalmology2026
Early outcomes of combined suture gonioscopy-assisted transluminal trabeculotomy and phacoemulsification in Indian eyes: A retrospective study.
Article in Indian journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo analyze early outcomes and safety profiles of combined phacoemulsification and suture gonioscopy-assisted transluminal trabeculotomy (phaco-GATT) in Indian eyes with primary and secondary (pseudoexfoliative) glaucoma coexisting with cataract.
methodsIn this retrospective interventional analysis, 42 eyes with primary and secondary (pseudoexfoliative) glaucoma, all with coexisting cataract having follow-up of 6 months to 1 year, were included. Phacoemulsification with suture GATT was performed. Outcome measures included surgical success rate (complete and qualified), intraocular pressure (IOP) reduction post surgery, change in antiglaucoma medications (AGMs) post surgery, change in best corrected visual acuity, and surgical complications. IOP reduction <18 mmHg or ≥30% from baseline without AGM was defined as complete success. IOP reduction <18 mmHg or ≥30% from baseline with AGM was considered as qualified success.
resultsMean baseline IOP reduced significantly from 23.05+- 7.42 mmHg to 13.4+- 3.20 mmHg at 1 year ( P < 0.001, n = 30), with a 44% IOP reduction. Mean AGM use decreased from 1.93+- 0.52 to 0.13+-0.43 at 1 year ( P < 0.001, n = 30). The complete and qualified success rates at 1 year were 90% and 93%, respectively. BCVA improved from 0.533+- 0.36 logMAR to 0.013+-0.050 logMAR ( P < 0.001). Common complications were IOP spikes (19%) and transient hyphema (16%), all resolving without major intervention.
conclusionCombined phaco-GATT is a cost-effective and safe surgery with favorable early outcomes, providing significant IOP reduction, reduced medication burden, and minimal complications in patients with primary and secondary (pseudoexfoliative) glaucoma. As a conjunctiva sparing technique, it preserves future surgical options and may delay or avoid need for trabeculectomy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.